mAbs to Bacillus anthracis capsular antigen for immunoprotection in anthrax and detection of antigenemia.
about
Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthraxKinetics of lethal factor and poly-D-glutamic acid antigenemia during inhalation anthrax in rhesus macaquesAnthrax vaccination strategiesMonoclonal antibody therapies against anthraxDetection of B. anthracis spores and vegetative cells with the same monoclonal antibodies.IgG subclass and heavy chain domains contribute to binding and protection by mAbs to the poly γ-D-glutamic acid capsular antigen of Bacillus anthracis.Immunogenicity and protective efficacy of Bacillus anthracis poly-gamma-D-glutamic acid capsule covalently coupled to a protein carrier using a novel triazine-based conjugation strategy.Additional conjugation methods and immunogenicity of Bacillus anthracis poly-gamma-D-glutamic acid-protein conjugatesRecombinant protective antigen 102 (rPA102): profile of a second-generation anthrax vaccine.Protective and immunochemical activities of monoclonal antibodies reactive with the Bacillus anthracis polypeptide capsuleAmino acid alphabet size in protein evolution experiments: better to search a small library thoroughly or a large library sparsely?Immunogenicity of Bacillus anthracis protective antigen domains and efficacy of elicited antibody responses depend on host genetic background.Bacillus anthracis capsule activates caspase-1 and induces interleukin-1beta release from differentiated THP-1 and human monocyte-derived dendritic cells.Biosensing with nanofluidic diodes.Capsule synthesis by Bacillus anthracis is required for dissemination in murine inhalation anthraxKey role of poly-gamma-DL-glutamic acid in immune evasion and virulence of Staphylococcus epidermidis.Identification of Burkholderia cepacia complex bacteria with a lipopolysaccharide-specific monoclonal antibody.Exposure to Bacillus anthracis capsule results in suppression of human monocyte-derived dendritic cellsPolysaccharide specific monoclonal antibodies provide passive protection against intranasal challenge with Burkholderia pseudomallei.Panning of a phage display library against a synthetic capsule for peptide ligands that bind to the native capsule of Bacillus anthracisCathelicidin administration protects mice from Bacillus anthracis spore challengePre- and postexposure protection against virulent anthrax infection in mice by humanized monoclonal antibodies to Bacillus anthracis capsuleImmunomodulation with CD40 stimulation and interleukin-2 protects mice from disseminated cryptococcosisDetection of anthrax toxin in the serum of animals infected with Bacillus anthracis by using engineered immunoassaysIdentification of circulating bacterial antigens by in vivo microbial antigen discovery.The poly-γ-D-glutamic acid capsule of Bacillus anthracis enhances lethal toxin activity.Toxin-deficient mutants of Bacillus anthracis are lethal in a murine model for pulmonary anthraxImmunoassay for Capsular Antigen of Bacillus anthracis Enables Rapid Diagnosis in a Rabbit Model of Inhalational Anthrax.Antibodies against anthrax: mechanisms of action and clinical applications.Poly-gamma-glutamate capsule-degrading enzyme treatment enhances phagocytosis and killing of encapsulated Bacillus anthracisBacillus anthracis Capsular Conjugates Elicit Chimpanzee Polyclonal Antibodies That Protect Mice from Pulmonary Anthrax.Analysis of epitope information related to Bacillus anthracis and Clostridium botulinum.The Poly-γ-d-Glutamic Acid Capsule Surrogate of the Bacillus anthracis Capsule Is a Novel Toll-Like Receptor 2 Agonist.The evolving field of biodefence: therapeutic developments and diagnostics.Monoclonal antibodies and toxins--a perspective on function and isotype.Expression of either lethal toxin or edema toxin by Bacillus anthracis is sufficient for virulence in a rabbit model of inhalational anthraxIn vivo Distribution and Clearance of Purified Capsular Polysaccharide from Burkholderia pseudomallei in a Murine Model.Treatment of experimental anthrax with recombinant capsule depolymeraseIn vivo fate and distribution of poly-gamma-D-glutamic acid, the capsular antigen from Bacillus anthracis.Past, imminent and future human medical countermeasures for anthrax.
P2860
Q24682011-7C1747DA-FE85-40CD-9E71-A2737E60D686Q28389893-ADD96730-3709-4DC0-9129-3D04E8CACD43Q28392248-C4DD8470-64A4-4BCF-BA9B-F3E53F79BC1DQ28393072-157528C9-8DEB-4C7D-85BD-1A724994E97DQ30885995-859D411E-6F8D-4C64-A911-60C58AFD8B53Q31116360-DA50F35C-4C3B-436A-885D-84B9D035A0A9Q33227409-82306581-A4A8-4375-9861-813A91EC204FQ33251442-BECA4ECC-6738-469D-8812-2313326CC60FQ33258307-52AF5B4B-C60E-4942-AE78-EF564950E017Q33261310-F0167807-EA5F-43B8-9E2E-9C43283302D8Q33326227-9CE65F8D-A550-4679-BC36-E2399FDC3D78Q33334776-8D3A3235-5A24-4FDB-8713-41825AEC51BAQ33557788-EF4E3CC9-37D2-4C81-8AF1-8D6CA522437BQ33641004-D0A7B72B-0C0F-4A4A-A717-C80486FE1AB0Q33739694-C9B4FCF8-261D-412F-9B70-DCD10145E8C9Q33778606-8E9C96EB-3F49-4A75-AF7D-7E11474386B9Q33920487-846BFF8C-10EE-475E-8155-3C75E98435C5Q34059054-AB1EF3C5-161F-475E-B7BF-6AF0237B43AFQ34243707-B2BADC04-940F-4DCB-B0F0-E088176305B0Q34429143-A6140748-0765-4006-9D17-644726BD77ADQ34476038-FBFD159E-D7EB-4E64-916E-961AA4EFB5BAQ34490786-84A34B18-5410-4A74-B470-E0A19EAD18BDQ34492622-C1C4A6CF-BA9D-41B3-BD09-7AF1CE0F5AE4Q34720183-E844455F-81EC-4192-A28B-64F80E489AAEQ35187007-46C21CF3-4C03-4C13-83A9-F800E80934EFQ35191941-436BC1A2-D354-4D17-82CF-6EE2CC02ED7DQ35217494-FBAD9B8B-1D99-4024-962B-E3DEC1CA88D9Q35571163-E723C25C-09C6-478F-9AFD-3898EB078A32Q35610439-6B728796-37B4-40CF-A489-B83008CE6041Q35635634-25E22409-9DE1-4485-B3FA-03B3611C896AQ35652068-307A8F8B-20BA-4383-A64A-48E173AF0153Q35869311-12CA1BC6-B474-41BC-B52E-2A65D0E519D4Q36053487-6835D612-2C66-41D6-A7CF-B68F4254B660Q36085668-296DAF89-F3D9-40E6-A05E-AFE736F27542Q36099489-DBA0855A-30E5-410F-9A74-BA2B5E708173Q36155940-48E8E379-1DF4-4419-ACD0-FC00EE7C16A7Q36219974-4F2DFB87-0CEC-4D15-8479-6FB272F65DC2Q36482838-A368F84D-E6A0-40C0-92E1-CE7D60C2674AQ36483647-947203F0-27C3-48E3-9F25-D058ACD58A26Q36565152-0E4D3777-B801-49ED-9723-262AB91A5C6A
P2860
mAbs to Bacillus anthracis capsular antigen for immunoprotection in anthrax and detection of antigenemia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 March 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
mAbs to Bacillus anthracis cap ...... and detection of antigenemia.
@en
mAbs to Bacillus anthracis cap ...... and detection of antigenemia.
@nl
type
label
mAbs to Bacillus anthracis cap ...... and detection of antigenemia.
@en
mAbs to Bacillus anthracis cap ...... and detection of antigenemia.
@nl
prefLabel
mAbs to Bacillus anthracis cap ...... and detection of antigenemia.
@en
mAbs to Bacillus anthracis cap ...... and detection of antigenemia.
@nl
P2093
P2860
P356
P1476
mAbs to Bacillus anthracis cap ...... and detection of antigenemia.
@en
P2093
Ann Percival
C Rick Lyons
Julie A Lovchik
Peter Thorkildson
Suzanne Brandt
William J Murphy
P2860
P304
P356
10.1073/PNAS.0401351101
P407
P577
2004-03-29T00:00:00Z